You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 6, March 22, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •HIV/AIDS
 •Diagnosis
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Screening for Primary Human Immunodeficiency Virus Infection

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Weintrob et al1 recently pointed out the infrequency in diagnosis of primary human immunodeficiency virus (HIV) infection by performing HIV RNA polymerase chain reaction (PCR) in patients who present with viral syndrome and have risk factors for HIV infection. However, they do not address cost-effectiveness of this strategy and the use of empirical antiretroviral therapy.

Fever, fatigue, myalgias, weight loss, headache, and nausea are nonspecific and common presenting symptoms in non–HIV-infected patients. The major risk factor for HIV transmission, an unprotected sexual intercourse, is also common. Because the cost of HIV RNA PCR testing is not insignificant,2 the authors should provide the total number of patients screened in the study. In addition, as they mentioned, initiation of antiretroviral therapy soon may reduce the long-lived, latently infected lymphocytes that act as a reservoir for HIV. I wonder if the authors initiate their screened patients on preemptive antiviral therapy until the test . . . [Full Text of this Article]

Tawee Tanvetyanon, MD
Maywood, Ill



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Screening for Primary Human Immunodeficiency Virus Infection—Reply
Charles Hicks and Amy Weintrob
Arch Intern Med. 2004;164(6):680.
EXTRACT | FULL TEXT  

Infrequent Diagnosis of Primary Human Immunodeficiency Virus Infection: Missed Opportunities in Acute Care Settings
Amy C. Weintrob, Julieta Giner, Prema Menezes, Ericka Patrick, Daniel Kelly Benjamin, Jr, Jeffrey Lennox, Christopher D. Pilcher, Joseph J. Eron, and Charles B. Hicks
Arch Intern Med. 2003;163(17):2097-2100.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.